Cite
A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.
MLA
Brooke, Russell J., et al. “A High-Risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.” JNCI: Journal of the National Cancer Institute, vol. 110, no. 8, Aug. 2018, pp. 895–904. EBSCOhost, https://doi.org/10.1093/jnci/djx281.
APA
Brooke, R. J., Im, C., Wilson, C. L., Krasin, M. J., Liu, Q., Li, Z., Sapkota, Y., Moon, W., Morton, L. M., Wu, G., Wang, Z., Chen, W., Howell, R. M., Armstrong, G. T., Bhatia, S., Mostoufi-Moab, S., Seidel, K., Chanock, S. J., Zhang, J., & Green, D. M. (2018). A High-risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy. JNCI: Journal of the National Cancer Institute, 110(8), 895–904. https://doi.org/10.1093/jnci/djx281
Chicago
Brooke, Russell J, Cindy Im, Carmen L Wilson, Matthew J Krasin, Qi Liu, Zhenghong Li, Yadav Sapkota, et al. 2018. “A High-Risk Haplotype for Premature Menopause in Childhood Cancer Survivors Exposed to Gonadotoxic Therapy.” JNCI: Journal of the National Cancer Institute 110 (8): 895–904. doi:10.1093/jnci/djx281.